Scarica l'app Stockscreener
1.08
6.09%
-0.07
Dopo l'orario di chiusura:
1.08
Precedente Chiudi:
$1.15
Aprire:
$1.15
Volume 24 ore:
120.71K
Relative Volume:
0.34
Capitalizzazione di mercato:
$46.12M
Reddito:
$24.38M
Utile/perdita netta:
$-53.95M
Rapporto P/E:
-0.4372
EPS:
-2.47
Flusso di cassa netto:
$-23.31M
1 W Prestazione:
-0.92%
1M Prestazione:
+2.86%
6M Prestazione:
-15.62%
1 anno Prestazione:
-66.77%
Intervallo 1D:
$1.06
$1.19
Intervallo di 1 settimana:
$1.06
$1.22
Portata 52W:
$0.50
$3.46
Elutia Inc Stock (ELUT) Company Profile
Nome
Elutia Inc
Settore
Industria
Telefono
240-247-1143
Indirizzo
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
1.08 | 46.12M | 24.38M | -53.95M | -23.31M | -2.47 |
|
ABT
Abbott Laboratories
|
108.03 | 187.72B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
336.77 | 128.88B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.14 | 111.88B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.13 | 102.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.81 | 47.52B | 6.07B | 1.06B | 1.34B | 1.8063 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-11-02 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-11-02 | Iniziato | Cowen | Outperform |
| 2020-11-02 | Iniziato | Piper Sandler | Overweight |
| 2020-11-02 | Iniziato | Truist | Buy |
Elutia Inc Borsa (ELUT) Ultime notizie
Elutia (ELUT) Grants Stock Options to New Hires - GuruFocus
Elutia announces grants of inducement awards - TipRanks
Exit Recap: Is Elutia Inc subject to activist investor interest2026 Market Mood & Detailed Earnings Play Strategies - baoquankhu1.vn
Elutia 2025 10-K: Revenue $12.3M, EPS (cont. ops) $(15.871)M - TradingView
Elutia (NASDAQ: ELUT) pivots to drug‑eluting biomatrix after asset divestitures - Stock Titan
Achieving Micron-Level Tolerances: CAD Optimization for Sub-10µm 3D Printing - AOL.com
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - Bitget
Elutia markets another product for sale as it pivots to breast reconstruction infection prevention - The Business Journals
Elutia grants 460,000 stock options to 3 new hires at $1.09 - Stock Titan
Elutia (ELUT) Q4 2025 Earnings Call Transcript - AOL.com
Elutia Inc. (NASDAQ:ELUT) Q4 2025 earnings call transcript - MSN
[Form 4] ELUTIA INC. Insider Trading Activity - Stock Titan
Elutia Q4 2025 slides: $88M sale funds pivot to breast reconstruction - Investing.com Australia
Elutia Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:ELUT) 2026-03-12 - Seeking Alpha
Elutia Reports Strong 2025 Financial Results, Advances NXT-41x for Breast Cancer Surgery, and Closes $88M BioEnvelope Sale to Boston Scientific - Minichart
Elutia Inc (ELUT) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic Moves Amid ... By GuruFocus - Investing.com Canada
Elutia Inc (ELUT) Q4 2025 Earnings Call Highlights: Revenue Grow - GuruFocus
Elutia Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Elutia Reports Fourth Quarter and Full Year 2025 Financial Results; Initiates NXT-41 Regulatory Process - Bitget
Earnings call transcript: Elutia Q4 2025 beats forecasts, stock steady By Investing.com - Investing.com Australia
Earnings call transcript: Elutia Q4 2025 beats forecasts, stock steady - Investing.com India
Elutia Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Elutia earnings beat by $1.60, revenue topped estimates - Investing.com Canada
Elutia reports $3.3M Q4 revenue, $70.8M net income on BioEnvelope sale; $44.4M year-end cash - TradingView
ELUTIA ($ELUT) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
Elutia Q4 revenue rises on higher cardiovascular product sales - TradingView
ELUT: Q4 net income soared to $70.8M on BioEnvelope sale, with NXT-41x FDA process underway - TradingView
Elutia Inc. Adopts 2026 Inducement Award Plan and Files Form 8-K Disclosure - Minichart
Exploring Elutia's Earnings Expectations - Benzinga
Elutia Inc (ELUT) Q4 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
Elutia Adopts 2026 Inducement Equity Award Plan - TipRanks
Elutia Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Elutia Regains Full Nasdaq Compliance, Strengthening Listing Status - The Globe and Mail
Elutia (ELUT) Expected to Announce Earnings on Wednesday - MarketBeat
Elutia regains compliance with Nasdaq listing requirements - Investing.com Australia
Elutia regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Canada
Elutia regains Nasdaq compliance after meeting minimum bid price and MVLS - TradingView
Elutia Regains Compliance with Nasdaq Listing Requirements - Bitget
Elutia (NASDAQ: ELUT) regains full Nasdaq listing compliance after bid price, value breach - Stock Titan
Elutia names Pete Ligotti chief commercial officer - Investing.com
Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market - Bitget
Elutia Selects Pete Ligotti as CCO to Lead the Commercial - GlobeNewswire
Elutia names Pete Ligotti chief commercial officer By Investing.com - Investing.com UK
ELUT Should I Buy - Intellectia AI
Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026 - Bitget
ELUT SEC FilingsElutia Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Elutia schedules March 11 webcast for Q4 2025 financials - Stock Titan
ELUT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Interview with the President and CEO: Elutia Inc. (NASDAQ:ELUT) - The Wall Street Transcript
Short Squeeze: What is the PEG ratio of Brookdale Senior Living IncStock Surge & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification - HRTech Series
Elutia Inc Azioni (ELUT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.66%
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):